Eosinophils in COPD: just another biomarker?

Eosinophils in COPD: just another biomarker?

Eosinophils are innate immune cells that, under certain conditions, can be recruited to the lungs, where they have an incompletely understood role in health and disease. Eosinophils have been found in the airways, tissues, and circulation of patients with COPD, during both stable disease and exacerb...

Descripció completa

Dades bibliogràfiques
Autors principals:	Bafadhel, M, Pavord, I, Russell, R
Format:	Journal article
Idioma:	English
Publicat:	Elsevier 2017

Ítems similars

Copd in the ed: eosinophils, treatment and outcomes, data from the pre-award study
per: Russell, R, et al.
Publicat: (2016)

Characterising non-eosinophilic COPD
per: Hambleton, K, et al.
Publicat: (2015)

Investigating blood eosinophil count thresholds in patients with COPD
per: Russell, R, et al.
Publicat: (2018)

Blood eosinophil levels as a biomarker in COPD
per: Brusselle, G, et al.
Publicat: (2018)

Seasonality of eosinophilic and non-eosinophilic exacerbations of COPD
per: Barker, R, et al.
Publicat: (2017)

The peripheral blood eosinophil count as a biomarker of eosinophilic airway inflammation in patients with asthma and COPD. Experience from a single centre
per: Shrimanker, R, et al.
Publicat: (2017)

Mepolizumab for eosinophilic COPD
per: Sciurba, F, et al.
Publicat: (2018)

Blood eosinophil guided prednisolone therapy for exacerbations of COPD: a further analysis.
per: Bafadhel, M, et al.
Publicat: (2014)

Peripheral blood eosinophil drop-to-drop variation in patients with COPD using near patient testing: a small validation study
per: Jeffers, H, et al.
Publicat: (2017)

The significance of eosinophilic inflammation in COPD
per: Cooper, C, et al.
Publicat: (2017)

Blood eosinophil count and GOLD stage predict response to maintenance azithromycin treatment in COPD patients with frequent exacerbations
per: Djamin, R, et al.
Publicat: (2019)

Blood eosinophils: a biomarker of COPD exacerbation reduction with inhaled corticosteroids
per: Siddiqui, S, et al.
Publicat: (2018)

Blood Eosinophils and outcomes in severe hospitalized exacerbations of COPD
per: Bafadhel, M, et al.
Publicat: (2016)

Biomarkers in COPD
per: Ramakrishnan, S, et al.
Publicat: (2021)

Blood eosinophils: a biomarker of COPD exacerbation reduction with inhaled corticosteroids
per: Siddiqui SH, et al.
Publicat: (2018-11-01)

Eosinophil migration is enhanced towards IL-5 and eotaxin in COPD
per: Lababidi, R, et al.
Publicat: (2017)

Case series of long-term macrolide therapy effect on eosinophil count in COPD
per: Asciak, R, et al.
Publicat: (2017)

Blood eosinophils to guide inhaled maintenance therapy in a primary care COPD population
per: Helen F. Ashdown, et al.
Publicat: (2021-02-01)

Can NPT be used to distinguish eosinophilic inflammatory phenotypes in COPD?
per: Hambleton, K, et al.
Publicat: (2016)

Blood eosinophil count and exacerbation risk in patients with COPD.
per: Kerkhof, M, et al.
Publicat: (2017)

Inhaled glucocorticoids and COPD exacerbations.
per: Brightling, C, et al.
Publicat: (2015)

Mepolizumab for Eosinophilic Chronic Obstructive Pulmonary Disease (COPD): A Meta-Analysis of METREX and METREO Exacerbation Endpoints
per: Bafadhel, M, et al.
Publicat: (2018)

Sputum Il-17a levels correlate with biomarkers of non-eosinophilic inflammation in patients with asthma
per: Hynes, G, et al.
Publicat: (2017)

The acute wheezy adult with airways disease in the emergency department: a retrospective case-note review of exacerbations of COPD
per: Russell, R, et al.
Publicat: (2019)

Just another diabetic
per: Rubayet Arefin
Publicat: (2019-11-01)

Just another chalazion?
per: Jonathan McLaughlin, et al.
Publicat: (2019-01-01)

Not just another genome
per: Tautz Diethard
Publicat: (2011-02-01)

Blood eosinophil count as a prognostic biomarker in COPD
per: Oh YM, et al.
Publicat: (2018-10-01)

The association between blood eosinophils and risk and treatment outcome in COPD is not dichotomised
per: Pascoe, S, et al.
Publicat: (2018)

Biomarkers for severe eosinophilic asthma.
per: Yancey, S, et al.
Publicat: (2017)

COPD exacerbation severity and frequency is associated with impaired macrophage efferocytosis of eosinophils
per: Eltboli, O, et al.
Publicat: (2014)

Shall we focus on the eosinophil to guide treatment with systemic corticosteroids during acute exacerbations of COPD?: PRO
per: Camp, J, et al.
Publicat: (2018)

Doxofylline is not just another theophylline!
per: Matera MG, et al.
Publicat: (2017-12-01)

Are blood eosinophils a prime-time biomarker for COPD management decisions?
per: Tsiligianni I, et al.
Publicat: (2018-06-01)

The acute wheezy adult with airways disease in the emergency department: a retrospective case-note review of exacerbations of COPD
per: Russell REK, et al.
Publicat: (2019-05-01)

Association between blood eosinophil count and risk of exacerbations in patients with COPD
per: Kerkhof, M, et al.
Publicat: (2017)

Are COPD and cardiovascular disease fundamentally intertwined?
per: Bafadhel, M, et al.
Publicat: (2016)

Not Just Another Pretty Picture
per: Hilary Davis
Publicat: (2009-11-01)

Mepolizumab for Eosinophilic Chronic Obstructive Pulmonary Disease (COPD): A Meta-Analysis of METREX and METREO Patient-Reported Outcomes, Response to Therapy and Lung Function
per: Chapman, K, et al.
Publicat: (2018)

Shall We Focus on the Eosinophil to Guide Treatment with Systemic Corticosteroids during Acute Exacerbations of COPD?: PRO
per: James Camp, et al.
Publicat: (2018-09-01)